Efficacy and diabetes risk of moderate-intensity statin plus ezetimibe versus high-intensity statin after percutaneous coronary intervention: A systematic review and meta-analysis.
- DOI
- 10.1016/j.jacl.2026.07.036
- Published
- 2026 Aug 4
- Container
- Journal of clinical lipidology
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.jacl.2026.07.036,
title = {Efficacy and diabetes risk of moderate-intensity statin plus ezetimibe versus high-intensity statin after percutaneous coronary intervention: A systematic review and meta-analysis.},
author = {Kelly FA and Moreira Rêgo LHR and Rebelo TG and da Silva RM and Pessoa FR and Falcao V},
year = {2026},
journal = {Journal of clinical lipidology},
doi = {10.1016/j.jacl.2026.07.036},
url = {https://doi.org/10.1016/j.jacl.2026.07.036}
}RIS
TY - JOUR TI - Efficacy and diabetes risk of moderate-intensity statin plus ezetimibe versus high-intensity statin after percutaneous coronary intervention: A systematic review and meta-analysis. AU - Kelly FA AU - Moreira Rêgo LHR AU - Rebelo TG AU - da Silva RM AU - Pessoa FR AU - Falcao V PY - 2026 JO - Journal of clinical lipidology DO - 10.1016/j.jacl.2026.07.036 UR - https://doi.org/10.1016/j.jacl.2026.07.036 ER -
APA
FA, K., LHR, M. R., TG, R., RM, D. S., FR, P., & V, F. (2026). Efficacy and diabetes risk of moderate-intensity statin plus ezetimibe versus high-intensity statin after percutaneous coronary intervention: A systematic review and meta-analysis.. Journal of clinical lipidology. https://doi.org/10.1016/j.jacl.2026.07.036
Source records
- pubmed · retrieved 2026-09-25T12:47:21.615Z